By now, you’ve likely heard about GLP-1 medications. Ozempic, Wegovy, and Mounjaro are everywhere—on the news, at dinner tables, in your doctor’s office. Originally for type 2 diabetes, these drugs have become a social phenomenon, mostly because of their remarkable weight loss effects. For many Americans, it seemed like a long-awaited solution. But if you’re…